Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02455297
Title Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Age Groups: adult
Covered Countries USA

No variant requirements are available.